Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год

Применить Всего найдено 12. Отображено 12.
21-07-2022 дата публикации

ANTIBACTERIAL AGENTS & METHODS

Номер: US20220226396A1
Принадлежит:

The invention relates to means for carrying out conjugation between bacteria, and in particular the invention relates to carrier bacteria comprising antimicrobial agents and methods of use. The carrier bacteria are capable of conjugative transfer of DNA encoding the agent to a target cells. The invention further relates to growth or feed conversion ratio promotion in animals. The invention further relates to killing Salmonella or inhibiting the growth or proliferation of Salmonella.

Подробнее
09-04-2015 дата публикации

Probiotic Formulation

Номер: US20150098929A1
Принадлежит: The University of Bristol

A probiotic organism which is capable of proliferation in iron-rich media, an environment which is generally unfavourable to probiotic organisms, is described. 1Streptococcus thermophilus. A spp. which is able to increase growth rate in a mixed population environment in response to increased iron availability.2Streptococcus thermophilus. A spp. according to claim 1 , which is able to sustain its increase its growth rate in the presence of iron in a mixed population environment for more than one day.3Streptococcus thermophilus. A spp. according to claim 2 , which is able to grow in a mixed population environment at the concentrations of iron encountered during periods of intestinal bleeding.4Streptococcus thermophilus. A spp. according to which is able to survive claim 1 , reproduce and grow in a mixed population environment in an iron-rich growth medium for at least three days.5Streptococcus thermophilus. A spp. according to which is tolerant of low pH.6Streptococcus thermophilus. A spp. according to which is able to survive at gastric pH.7Streptococcus thermophilus. A spp. according to or which is able to survive claim 5 , reproduce and grow in a low pH growth medium for at least three days.8Streptococcus thermophilus. A spp. according to in which the low pH is a pH of between 1 and 3.5.9Streptococcus thermophilus. A spp. according to in which the low pH is a pH of 2.10Streptococcus thermophilus. A spp. according to claim 1 , which is able to act locally to reduce the level of inflammation.11Streptococcus thermophilus. A spp. according to claim 1 , in which the inflammation is chronic.12Streptococcus thermophilus. A spp. according to comprising a DNA sequence to which the primers M13 (5′-gagggtggcggttct-3′) and MSP (5′-gtaaaacgacggccagt-3′) bind in the presence of Magnesium chloride at 7.2 mM and when incubated at 95° C. for 2 minutes and then 60 cycles of 94° C. for 30 seconds claim 1 , 45° C. for 30 seconds and 72° C. for 80 seconds followed by a final period of ...

Подробнее
22-09-2022 дата публикации

Small Molecule Agents, Compositions, and Formulations, for Internal Use, Displaying Inhibitory Activity Against Gram-positive and/or Gram-negative Organisms

Номер: US20220296549A1
Принадлежит: NATUREZA, INC.

Active components comprising lauric acid, or a lauric acid derivative, are utilized independently, or in combination, to provide new and useful compositions for bacteriostatic action against susceptible pathogens. The lauric acid derivative includes one or more of 12-aminododecanoic acid, 12-amino-1-dodecanoic acid methyl ester, sucrose monolaurate, 12-(7-nitrobenzofurazan-4-ylamino) dodecanoic acid, 4-nitrophenyl dodecanoate, 1-lauroyl-rac-glycerol, 3-oxo-N-(2-oxocyclohexyl) dodecanamide, butyl laurate, benzyl laurate, isoamyl laurate, monolaurin, isopropyl laurate, pentyl laurate, and hexyl laurate. A preparation includes combining the active component with lecithin, and after an initial processing phase, coating with chitosan or a carrier. Final compositions may be or may contain particles, such as nanoparticles. Final compositions, or formulations containing said final compositions, may be utilized internally, causing one or more membrane changes (e.g., a membrane of an internal target pathogen, which may or may not be an antibiotic-resistant pathogen). At least some compositions inhibit growth of one or more Gram-positive bacterial species and one or more Gram-negative bacterial species. 1. A composition having broad spectrum antimicrobial action comprising:a lauric acid derivative as an active component of the composition, the lauric acid derivative being one of a strongly hydrophobic 12-carbon chain fatty acid and a strongly hydrophobic 12-carbon chain fatty acid ester, each having one or more carbon-containing side chains, in which each lauric acid derivative also has a partition coefficient, P, and to be strongly hydrophobic its log P value will be less than 4; andlecithin components containing phospholipids and at least one bulky fatty acid having a carbon chain length from between about 14 and 20, and in an amount up to about 50 wt. % of the composition,wherein the composition is in a form of nanoparticles, and is suitable for utilization in a formulation ...

Подробнее
14-02-2019 дата публикации

Lauric acid derivatives displaying inhibitory activity against gram-positive and/or gram-negative organisms

Номер: CA3072197A1
Принадлежит: NATUREZA Inc

Active components comprising lauric acid, or a lauric acid derivative, are utilized independently, or in combination, to provide new and useful compositions for bacteriostatic action against susceptible pathogens. The lauric acid derivative includes one or more of 12-aminododecanoic acid, 12-amino-l-dodecanoic acid methyl ester, sucrose monolaurate, 12-(7-nitrobenzofurazan-4-ylamino) dodecanoic acid, 4-nitrophenyl dodecanoate, 1-lauroyl-rac-glycerol, 3-oxo-N-(2-oxocyclohexyl) dodecanamide, butyl laurate, benzyl laurate, isoamyl laurate, monolaurin, isopropyl laurate, pentyl laurate, and hexyl laurate. A preparation includes combining the active component with lecithin, and after an initial processing phase, coating with chitosan or a carrier. Final compositions may be or may contain particles, such as nanoparticles. Final compositions, or formulations containing said final compositions, may be utilized internally, causing one or more membrane changes (e.g., a membrane of an internal target pathogen, which may or may not be an antibiotic-resistant pathogen). At least some compositions inhibit growth of one or more Gram-positive bacterial species and one or more Gram-negative bacterial species.

Подробнее
19-11-2020 дата публикации

Antibacterial agents & methods

Номер: WO2020229372A1
Принадлежит: Folium Food Science Limited

The invention relates to means for carrying out conjugation between bacteria, and in particular the invention relates to carrier bacteria comprising antimicrobial agents and methods of use. The carrier bacteria are capable of conjugative transfer of DNA encoding the agent to a target cells. The invention further relates to growth or feed conversion ratio promotion in animals. The invention further relates to killing Salmonella or inhibiting the growth or proliferation of Salmonella .

Подробнее
07-06-2022 дата публикации

Small molecule agents, compositions, and formulations, for internal use, displaying inhibitory activity against gram-positive and/or gram-negative organisms

Номер: US11351134B2
Принадлежит: Natureza Products Inc

Active components comprising lauric acid, or a lauric acid derivative, are utilized independently, or in combination, to provide new and useful compositions for bacteriostatic action against susceptible pathogens. The lauric acid derivative includes one or more of 12-aminododecanoic acid, 12-amino-1-dodecanoic acid methyl ester, sucrose monolaurate, 12-(7-nitrobenzofurazan-4-ylamino) dodecanoic acid, 4-nitrophenyl dodecanoate, 1-lauroyl-rac-glycerol, 3-oxo-N-(2-oxocyclohexyl) dodecanamide, butyl laurate, benzyl laurate, isoamyl laurate, monolaurin, isopropyl laurate, pentyl laurate, and hexyl laurate. A preparation includes combining the active component with lecithin, and after an initial processing phase, coating with chitosan or a carrier. Final compositions may be or may contain particles, such as nanoparticles. Final compositions, or formulations containing said final compositions, may be utilized internally, causing one or more membrane changes (e.g., a membrane of an internal target pathogen, which may or may not be an antibiotic-resistant pathogen). At least some compositions inhibit growth of one or more Gram-positive bacterial species and one or more Gram-negative bacterial species.

Подробнее
29-03-2022 дата публикации

Antibacterial agents and methods

Номер: BR112021022239A2
Принадлежит: Folium Food Science Ltd

agentes e métodos antibacterianos. a presente invenção refere-se a meios para realizar a conjugação entre bactérias e, em particular, a invenção refere-se a bactérias transportadoras compreendendo agentes antimicrobianos e métodos de uso. as bactérias transportadoras são capazes de transferência conjugativa do dna que codifica o agente para as células alvo. a invenção refere-se ainda à promoção da relação crescimento ou conversão alimentar em animais. a invenção também refere-se a matar salmonella ou inibir o crescimento ou proliferação de salmonella. antibacterial agents and methods. the present invention relates to means for effecting conjugation between bacteria and, in particular, the invention relates to carrier bacteria comprising antimicrobial agents and methods of use. carrier bacteria are capable of conjugative transfer of the DNA encoding the agent to target cells. the invention further relates to promoting the growth or feed conversion ratio in animals. the invention also relates to killing salmonella or inhibiting the growth or proliferation of salmonella.

Подробнее
14-03-2013 дата публикации

Probiotic formulation

Номер: WO2013011320A3
Принадлежит: The University of Bristol

A probiotic organism which is capable of proliferation in iron-rich media, an environment which is generally unfavourable to probiotic organisms, is described.

Подробнее
28-05-2014 дата публикации

Probiotic formulation

Номер: EP2734057A2
Принадлежит: University of Bristol

A probiotic organism which is capable of proliferation in iron-rich media, an environment which is generally unfavourable to probiotic organisms, is described.

Подробнее
30-11-2020 дата публикации

Formulación probiótica

Номер: ES2796834T3
Принадлежит: University of Bristol

El Streptococcus thermophilus NCIMB 41856.

Подробнее
24-01-2013 дата публикации

Probiotic formulation

Номер: WO2013011320A2
Принадлежит: The University of Bristol

A probiotic organism which is capable of proliferation in iron-rich media, an environment which is generally unfavourable to probiotic organisms, is described.

Подробнее
25-09-2018 дата публикации

Probiotic formulation

Номер: US10080773B2
Принадлежит: University of Bristol

A probiotic organism which is capable of proliferation in iron-rich media, an environment which is generally unfavorable to probiotic organisms, is described.

Подробнее